PTPN11 and systemic sclerosis: The role of SHP2 in the vascular pathogenesis of SSc requires further investigation in murine models that resemble the vascular alterations in SSc such as Fra-2 transgenic mice or uPAR (urokinase-type plasminogen activator receptor) knockout mice55,56.